Mexican steel pipe manufacturers petitioned the federal government last week, asking that the second phase of The Ramones pipeline project include at least 50 percent of steel pipe manufactured in Mexico. Teodoro Gonzalez, CEO of ...
Tags: Mexican Pipe Producers, Domestic Content, Major Projects
Teva Pharmaceutical and Xenon Pharmaceuticals have announced the FDA orphan drug designation for analgesic XEN402 being developed to treat pain associated with erythromelalgia (EM). The novel chemical entity XEN402 is designed to inhibit ...
Tags: Pharmaceutical, FDA, Orphan Drug
OncoSec Medical, a US-based biotech company, has collaborated with Smart Patients to form a new online community for patients. The new online system enables patients to share their feedback and experiences who are looking for or who are ...
Tags: Oncosec Medical, Online Community
Activaero has reported the positive results from its phase II trial in children with mild to moderate asthma. The proof-of-concept trial was conducted with Activaero's drug-device combination consisting of budesonide in liquid formulation ...
Tags: Activaero, phase II trial, moderate asthma
Neuralstem has obtained notice of allowance for a patent that covers various methods to use expanded spinal cord stem cells such as NSI-566 to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The company completed Phase ...
The Directorate-General for Competition of the EU Commission has once again extended the deadline for the more detailed investigation (phase II investigation) of the planned merger of Munksj with the label & processing division of Ahlstrom. ...
Netherland-based ProFibrix has announced the completion of patient enrolment in pivotal Phase III trial with Fibrocaps (FINISH-3). The multicentre, randomised, single-blind study enrolled around 718 surgical patients with mild to moderate ...
The US FDA has approved Teva Pharmaceutical Industries' new drug application (NDA) for Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets as oral contraceptives. Quartette, designed as next generation of extended ...
Tags: Health, Medicine, oral contraceptives
Merck, referred to as MSD outside the US and Canada, and Luminex have signed a deal to develop a companion diagnostic device to support patient selection for the clinical development program of investigational drug MK-8931 to treat ...
Tags: companion diagnostic device, drug, Merck
Chimerix, a US-based company which discovers, develops and commercializes oral antiviral therapeutics, has won the US Food and Drug Administration (FDA) fast track designation for CMX001 for the prevention of cytomegalovirus (CMV) ...
Tags: Chimerix, oral antiviral therapeutics, FDA, CMX001
Moberg Derma has announced the discontinuation of the development of Limtop, an actinic keratosis drug, as it failed to reach the predefined efficacy target in a completed phase II trial. Moberg Derma president and CEO Peter Wolpert said ...
Tags: drug, Moberg Derma, actinic keratosis drug
India’s fast-growing cement industry can reduce its carbon emissions by nearly half by the middle of the century, according to a technology roadmap issued today by the International Energy Agency (IEA) and the World Business Council ...
Tags: IEA, WBCSD, Indian Cement Industry
Kraig Biocraft Laboratories, Inc., the leading developer of advanced spider silk based fiber technologies, announced that the first two stages of its Monster Silk pilot production program ("program") are running ahead of schedule and that ...
Tags: Kraig Biocraft Laboratories, advanced spider silk, fiber technologies
Phytopharm has announced results of its Phase II, randomised trial of Cogane in unmedicated patients with Parkinson's disease. More than four hundred subjects with early-stage Parkinson's disease were randomly chosen to receive either ...
Tags: PhytopharmPhase II, randomised trial, Parkinson's disease
Neurim Pharmaceuticals has announced positive results from a phase II clinical study reviewing the efficacy and safety of piromelatine. The novel investigational multimodal sleep medicine has been developed for the treatment of patients ...
Tags: Neurim Pharmaceuticals, positive results, phase II clinical study